Member Info for Moab

I think the market is clear as to what will happen at the 10.00 am meeting - another dose of smoke and mirrors, expectations based on SFA, and the same cr*p that has been spouted for years by AN. I live in hope that I am wrong, but to misquote, doing the same thing repeatedly and expecting a different result is a definition of insanity.

Is there any possibility that an announcement on Wednesday might be that AGL is being taken private?

Carrot

@ 08.21 "What can I say."

How about nothing for a change?

TGTD

Very useful summary. Makes a sensible change from the usual c&p on this board.

Eachetc,.

When was this email/communication from Paul Emmitt? Divvyup seems to think the contents are all your own work, and I take it they are not.

Thanks

Moab

Red

Agreed, the silence is worrying. As you say, nothing on performance. Would have been interesting to hear how FTU performs with different feedstocks - or even how it performs at all, particularly with sustained running over several days or longer. Not difficult to understand a SP 50% of its value before the CMD.

Castle

How interesting - to the self absorbed...

Castle

if you really have an IQ of 167 (which is Einsteinian), what the hell are you doing wasting time here?

Pat

Evidence, or is this a wild guess?

The new assay is not going to shoot the lights out.

So what are the workforce doing?

SS.1800

Please explain to us why this phase 1/2 study should / might be so important to AGL.

Thanks.

Carrot

" The other DNA analysis Companies, Thermo Fisher, Roche etc. seem to be asleep at the wheel. I see Illumina and Angle rapidly gaining market share offering the dual analysis. We will see!!!!!!!"

You have made this suggestion repeatedly, ad nauseam.

Could it be that the other DNA analysis companies have more insight into the possibilities and the market than you? (I know this is an bold suggestion, given your insight into AGL and broad knowledge of the subject.)

TwoGood2Die

I don't think your monica applies to AGL! AGL became a lost cause about 3 years ago when it became clear that the anticipated market, supplying hospitals directly and performing large numbers of analyses directly for hospitals was not going to take off. So a change of business model and rapid retrenchement was needed, and AGL had to shut down the US lab. Since then they have been working with, and are at the mercy of, pharma. There will never be enough pharma work, in my view, to make AGL a profitable outfit. Revenue, as has been have pointed out, is about 1/3 of running costs. Unsustainable. Unless someone comes and takes AGL out of its misery, it will fold. Someone might buy the IP but losses for all concerned will be substantial.

Jgbb

Indeed, stirring stuff from our beloved leader. Who, listening to him today could not have admired his fighting spirit, etc,. etc,.. Or not, perhaps. He truly cannot put sentences together that mean anything, simply flat sounding sound bites lumped into some sort of order. How ever did he become a lawyer?

Castle

All the good intentions: "We are forgetting PHE is about Reducing plastic waste" are fine, but what matters is that PHE, (and PIs) make money........

Meggiesdad

Thanks. Good publicity and if AFC get this right it will be a winner. Crucial that the purity of hydrogen (? .0005% NH3 ) remains high in order that fuel cells are not affected.

Not Constructivenews

We heard all this from you yesterday; anything original to add?

Silures

Too right; too many false dawns over the years.

Perhaps they have fallen for the same BS that has been peddled for years. I think even Newland believes his own cr*p.

I hope I am wrong as an LTH.